Loading...
Loading...
NEW YORK, NY · CIK 0001336528
Portfolio Value
$14.97B
Positions
8
New
2
Increased
1
Decreased
0
Sold Out
1
Pershing Square Capital Management, L.P. (NEW YORK, NY) reported a portfolio value of $14.97B across 8 positions in their Q1 2015 SEC 13F filing (period ending 2015-03-31). The top 10 positions account for 100.0% of the portfolio.
Top 8 holdings by portfolio weight. Block width = holding percentage. Green = new/increased, red = reduced, gray = unchanged.
| # | Stock | Value↓ | Weight | Change |
|---|---|---|---|---|
| 1 | VALEANT PHARMACEUTICALS INTL | $3.87B | 25.84% | New |
| 2 | APDAIR PRODS & CHEMS INC | $3.11B | 20.77% | - |
| 3 | CANADIAN PAC RY LTD | $2.55B | 17.01% | - |
| 4 | ZTSZOETIS INC | $1.94B | 12.93% | +0.6% |
| 5 | QSRRESTAURANT BRANDS INTL INC | $1.46B | 9.75% | - |
| 6 | PLATFORM SPECIALTY PRODS COR | $1.10B | 7.33% | - |
| 7 | HHC*HOWARD HUGHES CORP | $553.11M | 3.69% | - |
| 8 | ACTAVIS PLC | $401.30M | 2.68% | New |
| Stock | Value | Shares |
|---|---|---|
| VALEANT PHARMACEUTICALS INTL | $3.87B | 19,473,933 |
| ACTAVIS PLC | $401.30M | 1,348,358 |
Get alerts when Pershing Square Capital Management, L.P. files new 13F holdings.